NCT05214976 2022-12-22
A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
Jiangsu HengRui Medicine Co., Ltd.
Huabo Biopharm Co., Ltd.
SuZhou Stainwei Biotech Inc.
Nanjing Luye Sike Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Southern Europe New Drug Organization